How existing and emerging technologies can help stop the spread of a worldwide epidemic.
By Steve Melito, S&BP Editor
In October, Liberian Thomas Eric Duncan became the first person to die of Ebola in the U.S. after medical staff at Texas Health Presbyterian hospital initially misdiagnosed his condition. Later that month, the Food and Drug Administration (FDA) authorized the emergency use of the Center for Disease Control’s (CDC) Ebola Virus VP40 Real-Time RT-PCR assay on the 7500 Fast Dx Real-Time PCR instrument from Applied Biosystems (ABI), Inc. This polymerase chain reaction (PCR) instrument uses real-time nucleic acid amplification and five-color fluorescence detection for in vitro diagnostic use.